JP2013542954A5 - - Google Patents

Download PDF

Info

Publication number
JP2013542954A5
JP2013542954A5 JP2013537646A JP2013537646A JP2013542954A5 JP 2013542954 A5 JP2013542954 A5 JP 2013542954A5 JP 2013537646 A JP2013537646 A JP 2013537646A JP 2013537646 A JP2013537646 A JP 2013537646A JP 2013542954 A5 JP2013542954 A5 JP 2013542954A5
Authority
JP
Japan
Prior art keywords
polypeptide
wound healing
healing composition
polypeptide chain
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013537646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013542954A (ja
JP5815725B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/055319 external-priority patent/WO2012060832A1/en
Publication of JP2013542954A publication Critical patent/JP2013542954A/ja
Publication of JP2013542954A5 publication Critical patent/JP2013542954A5/ja
Application granted granted Critical
Publication of JP5815725B2 publication Critical patent/JP5815725B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013537646A 2010-11-03 2010-11-03 創傷治癒組成物およびその使用方法 Active JP5815725B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2010/055319 WO2012060832A1 (en) 2010-11-03 2010-11-03 Skin wound healing compositions and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2013542954A JP2013542954A (ja) 2013-11-28
JP2013542954A5 true JP2013542954A5 (cg-RX-API-DMAC7.html) 2014-01-16
JP5815725B2 JP5815725B2 (ja) 2015-11-17

Family

ID=46024739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013537646A Active JP5815725B2 (ja) 2010-11-03 2010-11-03 創傷治癒組成物およびその使用方法

Country Status (6)

Country Link
EP (1) EP2635293B1 (cg-RX-API-DMAC7.html)
JP (1) JP5815725B2 (cg-RX-API-DMAC7.html)
CN (1) CN103458914B (cg-RX-API-DMAC7.html)
CA (1) CA2816818C (cg-RX-API-DMAC7.html)
DK (1) DK2635293T3 (cg-RX-API-DMAC7.html)
WO (1) WO2012060832A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207118B2 (en) 2009-07-17 2012-06-26 University Of Southern California Skin wound healing compositions and methods of use thereof
KR102143557B1 (ko) * 2013-08-09 2020-08-12 주식회사 리제론 인간 열 활성화 단백질 90a의 절편을 유효성분으로 포함하는 피부상태 개선용 조성물
US9468654B1 (en) 2014-04-02 2016-10-18 Ali Razavi Drug delivery compositions and methods
CN108117594A (zh) * 2016-11-30 2018-06-05 财团法人工业技术研究院 促进细胞迁移及/或皮肤伤口愈合的肽、含该肽的医药组合物及其用途
CN107446018B (zh) * 2017-08-07 2020-07-17 温州千瑞生物科技有限公司 促进伤口愈合的肽及其应用
WO2022178005A1 (en) 2021-02-17 2022-08-25 Oxion Dental, Llc Stabilized active oxygen-generating antiseptic compositions, irrigation solutions, and articles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183805A (en) * 1990-08-13 1993-02-02 Board Of Regents, The University Of Texas System Bioactive egf peptides for promotion of tissue regeneration and cancer therapy
US6475490B1 (en) 1998-10-19 2002-11-05 Fordham University Compositions and methods for promoting tissue repair using heat shock proteins
US7081240B1 (en) 2000-06-28 2006-07-25 Zimmer Orthobiologics, Inc. Protein mixtures for wound healing
TWI305778B (en) * 2001-12-03 2009-02-01 Nishida Teruo Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use
US20070098735A1 (en) * 2005-10-29 2007-05-03 Chandawarkar Rajiv Y Methods for the Elimination of Pathogens and Other Particulate Agents
AU2006335748A1 (en) * 2006-01-23 2007-07-26 Imagene Co., Ltd. Novel peptide and use thereof
WO2008086358A1 (en) * 2007-01-08 2008-07-17 University Of Southern California Usc Stevens Skin wound healing compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
US9642895B2 (en) Peptides for enhancing transdermal delivery
JP2013542954A5 (cg-RX-API-DMAC7.html)
CY1110812T1 (el) Παραγωγα διφαινυλοξυοξικου οξεος για τη θεραπεια αναπνευστικων διαταραχων
WO2009011544A3 (en) Insulinotropic peptide derivative wherein its n-terminal amino acid is modified
JP2009526754A5 (cg-RX-API-DMAC7.html)
HRP20171048T1 (hr) Novi agonisti angiotenzinskog receptora tipa 2 (at2) i njihove upotrebe
JP2009539987A5 (cg-RX-API-DMAC7.html)
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
RU2012121562A (ru) Комбинация для лечения мукозита, индуцированного облучением или химиотерапией
ITTO20121107A1 (it) Composizione a base di polidesossiribonucleotidi e relativi usi
EA201291089A1 (ru) Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
JP2010536745A5 (cg-RX-API-DMAC7.html)
JP2018528978A5 (cg-RX-API-DMAC7.html)
WO2007093975A3 (es) Uso del factor pedf para inducir la renovación de células
NO20084478L (no) Konjugerte lipidderivater
SG162744A1 (en) Stable active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
RU2007101538A (ru) Применение фармацевтической композиции, содержащей кальцитриол и пропионат клобетазола, для лечения псориаза
KR20170052613A (ko) 효모/곰팡이에 의해 유발되는 감염을 치료하기 위한 시스테아민의 사용
JP2010523632A5 (cg-RX-API-DMAC7.html)
UA112345C2 (uk) Спосіб виготовлення за допомогою іонного желатинування інтестинальних альгінатних мікрокапсул, які містять диклофенак або одну із його солей, і багаточасткова фармацевтична композиція, що містить такі мікрокапсули
JP2013504519A5 (cg-RX-API-DMAC7.html)
WO2010012940A3 (fr) Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules
HK1203157A1 (en) Sustained delivery of molecules using peptide surfactants and uses thereof
JP2013147495A5 (cg-RX-API-DMAC7.html)
HRP20060079A2 (en) Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate